EKB Journal Management System
76.

Tertiary Structure Prediction and Analysis of the Non-structural Protein 5B of Hepatitis C Virus Genotype 4a

Volume 54, Issue 1, March 2022, Pages 57-65
Shaimaa Abd El-Ghany; A. A. El-Morsi; Mahmoud El-Bendary; Mustafa Neamatallah; Yehia A. Osman
77.

Hepatitis Post Cardiopulmonary Bypass in Children: Single Center Experience in Egypt

Volume 2, Issue 1, January 2022, Pages 82-88
Magd Ahmed Kotb; Fatma Al Zahraa Mostafa; Mohamed Abdelraouf Khalil; Mohamed Mohamed Abdelraouf; Lobna Ammar; Nahla I. Sabry
78.

Vestibular & Balance Assessment in Hepatitis C Virus Patients Undergoing (Sovaldi/Daklinza) Regimen

Volume 23, Issue 23, January 2022, Pages 1-6
Aya Magdy Elhusseiny; Amany shalaby; Hesham Mohamed Taha; Ossama Ashraf Ahmed
79.

Characterization of hepatocellular carcinoma in Mansoura university Hospitals: A case-control study of risk factors.

Volume 6.1, Issue 1, December 2021, Pages 38-45
Ahmed Ramadan; Gamal EL Ebidy; Maha Elzaafarany; Ahmed Galal; Maha Ibrahem; Dina Mohammed Ali
80.

Outcomes of direct acting antiviral therapy for treatment of HCV infection in patients with decompensated liver cirrhosis

Volume 6.1, Issue 1, December 2021, Pages 46-53
Doaa Bakr; Ibrahim Hassan; Elsayed Abd-Elmaksood; Ashraf Omar; Mahmoud Awad
81.

Genetic Variability of NS5B Region of Hepatitis C Virus in Togo

Volume 5.3, Issue 3, September 2021, Pages 8-13
Folly Anyovi; Alexandre Soulier; Lila Poiteau; Reham Soliman; Simplice D. Karou; Jacques Simpore; Stephane Chevaliez; Gamal Shiha
82.

Serum MiRNA-23a as a Diagnostic and Prognostic Biomarker of Hepatitis C Related Hepatocellular Carcinoma

Volume 51, Issue 2, August 2021, Pages 47-57
Marwa M. Fekry; Rasha I. Farrag; Heba S. Selim; Sarah L. Asser; Nermeen Abdeen
83.

Autotaxin as a marker for liver fibrosis in chronic HCV patients

Volume 2, Issue 2, July 2021, Pages 142-148
Safaa M Abd Razek; Magda Osman; Zakia A Mohammed; Wafaa El-zefzafy
84.

Assessment of Left Ventricular Systolic Function by Speckle Tracking in Diabetic Patients Receiving Direct Acting Antiviral Drugs for Chronic HCV

Volume 3, Issue 3, July 2021, Pages 1694-1699
Wael Anwar Hassib; Mohamed Gamil Abd Elraouf; Reda Biomy; Mohammed A. Hamouda; Mohamed Mahrous Ali Mohamed
85.

Assessment of erectile function and sexual hormones in chronic hepatitis C-infected patients treated with direct-acting antiviral agents

Volume 6, Issue 3, July 2021, Pages 287-290
Mohamed Abd Abd El-Mohsen; Ali M. Abd EL-Rahman; Mohamed Z. Abu Rahma; Ahmed Abdel-Aal Abdel-Mageed
86.

EFFECT OF DIRECT ACTING ANTIVIRAL (SOFOSBUVIR) ON DAILY LIVING ACTIVITIES OF PATIENTS WITH HEPATITIS C VIRUS

Volume 8, Issue 1, 2021, Pages 77-95
Huda Mahmoud Soliman; Eman Saleh Shaheen; amany gamal el gharib
87.

Assessment of the clinical value of red cell distribution width in patients with de novo hepatocellular carcinoma following HCV clearance with the direct-acting antiviral agents

Volume 5, Issue 2, June 2021, Pages 49-55
Haidi K. Ramadan; Eman M. Nagiub; Hanan A. Eltyb; Mahmoud Mohammed
88.

VALIDITY OF SERUM LEUKOTRIENE B4 AS A PREDICTIVE MARKER OF DECOMPENSATED LIVER CIRRHOSIS IN CHRONIC HCV PATIENTS

Volume 3, Issue 2, June 2021, Pages 21-22
Samar Raky El-Hewely
89.

Detection of Hepatitis C virus antibodies among healthy blood donors at a tertiary hospital in Nigeria

Volume 2, Issue 2, May 2021, Pages 252-259
AHANEKU IHERUE OSUJI; Georgina Chinenye Duru; Hauwa Kinjir
90.

Innate immune response in Plasmodium coinfection with HBV and HCV using complement C3, C4, and CD4 T cells

Volume 6, Issue 2, April 2021, Pages 208-214
Mathew F. Olaniyan; Tosan A. Erhabor; Elizabeth O. Okuori
91.

Liver Fibrosis Assessment in Cases of Chronic Hepatitis C after Direct Acting Antivirals Therapy using Aspartate Aminotransferase to Platelet Ratio Index and Transient Elastography

Volume 11, Issue 1, March 2021, Pages 10-17
Mohamed Eissa; Omar AbdAllah; Elsayed Ghoneem
92.

Circulating microRNA-221 as a diagnostic biomarker for hepatitis C virus-related hepatocellular carcinoma

Volume 2, Issue 1, February 2021, Pages 68-76
Awatef Awwad; Doaa El wazzan; Ayat Salem; Sara Asser
93.

Prevalence of Hepatitis B and CViruses among Health Care Workers at Governmental Hemodialysis Units

Volume 8, Issue 3, February 2021, Pages 183-202
Mona Hussein; Samar Abd El-Raouf; Mona EmadEldien
94.

Screening for hepatitis C virus infection by ELISA for South Valley University Students

Volume 4, Issue 1, January 2021, Pages 88-95
Manal A. Abdelrazek; Ahmed M. M. Hany; Mohammed A. Abdallah; Mohamed F. H. Alemam
95.

Effect of Direct Acting Anti-Hepatitis C Drugs on the Heart

Volume 82, Issue 1, January 2021, Pages 106-114
Mohamed Mahmoud Ahmed; Muhammad Abdel-Gawad; Mahmoud Ahmed Abd elbaset; Assem Elkady
96.

Study on Serum Cholinesterase as Marker of Chronic Liver Disease

Volume 2, Issue 1, 2020, Pages 1-15
Laila M. Aboughazala
97.

Efficacy and Safety of Ombitasvir, Paritaprevir and Ritonavir plus Ribavirin in Hepatitis C Genotype-4 Patients on Hemodialysis

Volume 4, Issue 2, December 2020, Pages 181-193
Mai Abdelmen; Nagwa Sabri; Sara Shahin; Ashraf Ahmed Aboubakr
98.

Prevalence and Predictors of Occult Hepatitis C Infection in High-Risk Egyptian Populations

Volume 10, Issue 4, December 2020, Pages 364-372
Mohammad M Sallam; Hanan S Ahmed; Hanan H Soliman; Sameh M Abdel Monem; Essam Abdel Wahab
99.

Evaluation of VCAM-1 and sPCAM-1 as biomarkers for the detection of hepatocellular carcinoma in patients with Hepatitis C virus

Volume 16, Issue 1, 2020, Pages 135-166
Tarek Sattar; Amal Ahmed Mohamed; Hoda Hegazy; Wafaa Shousha; Ahmed Refat Ezzat
100.

Correlation between the patients with Hepatitis C Virus and their Health-Related Quality of Life

Volume 008, Issue 1, December 2020, Pages 139-146
Ola Abd ElHamied; Hala Ibrahem Mohamed; Hend Elham Mohamed; Eman Fadl Abd Elkhalik
First Page Previous Page 1 2 3 4 5 6 7 8 Next Page Last Page